DME Capital Management’s Chemours CC Stock Holding History
Bought
Maintained
Sold
Other funds holding CC
DME Capital Management's CC Position: Q3 2022 in Review
DME Capital Management sold out of Chemours (CC) in Q3 2022, closing a stake of 700,000 shares — an estimated $22.4M sold.
DME Capital Management first reported a position in CC in Q4 2015 and held it in 23 quarters. The position peaked at $262M in Q3 2016. 488 funds tracked by Wall St. Rank hold CC as of Q3 2022.
- DME Capital Management reported no remaining Chemours position as of Q3 2022 after selling out during the quarter.
- DME Capital Management sold 700,000 Chemours shares in Q3 2022, an estimated $22.4M.
- DME Capital Management first reported a position in Chemours in Q4 2015 and held it in 23 quarters.
- DME Capital Management's Chemours position peaked at $262M in Q3 2016.
- 488 funds tracked by Wall St. Rank held Chemours as of Q3 2022.
Based on DME Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.